nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A1—chronic obstructive pulmonary disease	0.312	0.509	CbGaD
Toremifene—CYP1A2—chronic obstructive pulmonary disease	0.301	0.491	CbGaD
Toremifene—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0486	0.209	CbGbCtD
Toremifene—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0395	0.17	CbGbCtD
Toremifene—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0267	0.115	CbGbCtD
Toremifene—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0255	0.11	CbGbCtD
Toremifene—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0227	0.0978	CbGbCtD
Toremifene—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0222	0.0958	CbGbCtD
Toremifene—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.021	0.0904	CbGbCtD
Toremifene—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0133	0.0574	CbGbCtD
Toremifene—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0126	0.0542	CbGbCtD
Toremifene—Rigors—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.0103	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00992	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00992	CcSEcCtD
Toremifene—Skin discolouration—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00985	CcSEcCtD
Toremifene—Skin discolouration—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00985	CcSEcCtD
Toremifene—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00097	0.00928	CcSEcCtD
Toremifene—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.000911	0.00872	CcSEcCtD
Toremifene—Arthritis—Tiotropium—chronic obstructive pulmonary disease	0.000861	0.00823	CcSEcCtD
Toremifene—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000829	0.00793	CcSEcCtD
Toremifene—Abnormal vision—Arformoterol—chronic obstructive pulmonary disease	0.000811	0.00776	CcSEcCtD
Toremifene—Abnormal vision—Formoterol—chronic obstructive pulmonary disease	0.000811	0.00776	CcSEcCtD
Toremifene—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.000806	0.00771	CcSEcCtD
Toremifene—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.000801	0.00766	CcSEcCtD
Toremifene—Embolism—Prednisolone—chronic obstructive pulmonary disease	0.000785	0.00751	CcSEcCtD
Toremifene—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.000775	0.00741	CcSEcCtD
Toremifene—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000751	0.00718	CcSEcCtD
Toremifene—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00072	0.00689	CcSEcCtD
Toremifene—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.000704	0.00674	CcSEcCtD
Toremifene—Arthritis—Formoterol—chronic obstructive pulmonary disease	0.000695	0.00665	CcSEcCtD
Toremifene—Arthritis—Arformoterol—chronic obstructive pulmonary disease	0.000695	0.00665	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000677	0.00648	CcSEcCtD
Toremifene—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.000669	0.0064	CcSEcCtD
Toremifene—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000641	0.00613	CcSEcCtD
Toremifene—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000635	0.00608	CcSEcCtD
Toremifene—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.000628	0.006	CcSEcCtD
Toremifene—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00578	CcSEcCtD
Toremifene—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00573	CcSEcCtD
Toremifene—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000591	0.00566	CcSEcCtD
Toremifene—Embolism—Prednisone—chronic obstructive pulmonary disease	0.00057	0.00546	CcSEcCtD
Toremifene—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00544	CcSEcCtD
Toremifene—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00544	CcSEcCtD
Toremifene—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000568	0.00544	CcSEcCtD
Toremifene—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000564	0.0054	CcSEcCtD
Toremifene—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000564	0.00539	CcSEcCtD
Toremifene—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000559	0.00535	CcSEcCtD
Toremifene—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000558	0.00534	CcSEcCtD
Toremifene—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000548	0.00524	CcSEcCtD
Toremifene—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000542	0.00519	CcSEcCtD
Toremifene—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000541	0.00517	CcSEcCtD
Toremifene—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.00513	CcSEcCtD
Toremifene—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000525	0.00502	CcSEcCtD
Toremifene—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000522	0.00499	CcSEcCtD
Toremifene—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000517	0.00495	CcSEcCtD
Toremifene—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000513	0.00491	CcSEcCtD
Toremifene—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000513	0.00491	CcSEcCtD
Toremifene—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00488	CcSEcCtD
Toremifene—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00488	CcSEcCtD
Toremifene—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000507	0.00485	CcSEcCtD
Toremifene—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000504	0.00482	CcSEcCtD
Toremifene—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000501	0.00479	CcSEcCtD
Toremifene—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00478	CcSEcCtD
Toremifene—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000497	0.00475	CcSEcCtD
Toremifene—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.00466	CcSEcCtD
Toremifene—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.000486	0.00465	CcSEcCtD
Toremifene—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000482	0.00461	CcSEcCtD
Toremifene—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00461	CcSEcCtD
Toremifene—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00458	CcSEcCtD
Toremifene—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00454	CcSEcCtD
Toremifene—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.00451	CcSEcCtD
Toremifene—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000469	0.00449	CcSEcCtD
Toremifene—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00045	0.00431	CcSEcCtD
Toremifene—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.00431	CcSEcCtD
Toremifene—Clomifene—CYP1A1—chronic obstructive pulmonary disease	0.000444	0.251	CrCbGaD
Toremifene—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000432	0.00414	CcSEcCtD
Toremifene—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000429	0.0041	CcSEcCtD
Toremifene—Clomifene—CYP1A2—chronic obstructive pulmonary disease	0.000428	0.242	CrCbGaD
Toremifene—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000428	0.00409	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00408	CcSEcCtD
Toremifene—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000422	0.00404	CcSEcCtD
Toremifene—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00403	CcSEcCtD
Toremifene—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00403	CcSEcCtD
Toremifene—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000417	0.00399	CcSEcCtD
Toremifene—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.00399	CcSEcCtD
Toremifene—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000416	0.00398	CcSEcCtD
Toremifene—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000416	0.00398	CcSEcCtD
Toremifene—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00394	CcSEcCtD
Toremifene—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000412	0.00394	CcSEcCtD
Toremifene—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000412	0.00394	CcSEcCtD
Toremifene—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000411	0.00393	CcSEcCtD
Toremifene—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00041	0.00392	CcSEcCtD
Toremifene—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00391	CcSEcCtD
Toremifene—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00391	CcSEcCtD
Toremifene—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00389	CcSEcCtD
Toremifene—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00389	CcSEcCtD
Toremifene—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00386	CcSEcCtD
Toremifene—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000401	0.00383	CcSEcCtD
Toremifene—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00383	CcSEcCtD
Toremifene—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.00382	CcSEcCtD
Toremifene—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.0038	CcSEcCtD
Toremifene—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00379	CcSEcCtD
Toremifene—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000394	0.00377	CcSEcCtD
Toremifene—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000394	0.00377	CcSEcCtD
Toremifene—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00376	CcSEcCtD
Toremifene—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00376	CcSEcCtD
Toremifene—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000388	0.00372	CcSEcCtD
Toremifene—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.0037	CcSEcCtD
Toremifene—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00368	CcSEcCtD
Toremifene—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00367	CcSEcCtD
Toremifene—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00364	CcSEcCtD
Toremifene—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00364	CcSEcCtD
Toremifene—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.00363	CcSEcCtD
Toremifene—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00357	CcSEcCtD
Toremifene—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000372	0.00356	CcSEcCtD
Toremifene—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00355	CcSEcCtD
Toremifene—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.00036	0.00344	CcSEcCtD
Toremifene—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00344	CcSEcCtD
Toremifene—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.0034	CcSEcCtD
Toremifene—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000352	0.00336	CcSEcCtD
Toremifene—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.00331	CcSEcCtD
Toremifene—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000346	0.00331	CcSEcCtD
Toremifene—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000346	0.00331	CcSEcCtD
Toremifene—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.0033	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00329	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00329	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00322	CcSEcCtD
Toremifene—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00317	CcSEcCtD
Toremifene—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00317	CcSEcCtD
Toremifene—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00313	CcSEcCtD
Toremifene—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00311	CcSEcCtD
Toremifene—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00311	CcSEcCtD
Toremifene—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00311	CcSEcCtD
Toremifene—CYP1A1—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.000324	0.00662	CbGpPWpGaD
Toremifene—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00308	CcSEcCtD
Toremifene—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00308	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00032	0.00655	CbGpPWpGaD
Toremifene—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00305	CcSEcCtD
Toremifene—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000318	0.00304	CcSEcCtD
Toremifene—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00302	CcSEcCtD
Toremifene—CYP1A1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000314	0.00641	CbGpPWpGaD
Toremifene—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.003	CcSEcCtD
Toremifene—ESR1—Regulation of Telomerase—HDAC2—chronic obstructive pulmonary disease	0.000312	0.00639	CbGpPWpGaD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000309	0.00631	CbGpPWpGaD
Toremifene—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00295	CcSEcCtD
Toremifene—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00294	CcSEcCtD
Toremifene—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000307	0.00294	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000307	0.00627	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000306	0.00626	CbGpPWpGaD
Toremifene—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00291	CcSEcCtD
Toremifene—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.0029	CcSEcCtD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000302	0.00617	CbGpPWpGaD
Toremifene—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.00287	CcSEcCtD
Toremifene—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.0003	0.00287	CcSEcCtD
Toremifene—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00286	CcSEcCtD
Toremifene—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00283	CcSEcCtD
Toremifene—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00283	CcSEcCtD
Toremifene—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000294	0.00281	CcSEcCtD
Toremifene—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000293	0.165	CrCbGaD
Toremifene—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000291	0.00596	CbGpPWpGaD
Toremifene—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.00278	CcSEcCtD
Toremifene—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000289	0.00592	CbGpPWpGaD
Toremifene—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.00276	CcSEcCtD
Toremifene—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00275	CcSEcCtD
Toremifene—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00274	CcSEcCtD
Toremifene—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00274	CcSEcCtD
Toremifene—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000286	0.00274	CcSEcCtD
Toremifene—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000286	0.00274	CcSEcCtD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000284	0.00582	CbGpPWpGaD
Toremifene—Pain—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00271	CcSEcCtD
Toremifene—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00271	CcSEcCtD
Toremifene—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00271	CcSEcCtD
Toremifene—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00271	CcSEcCtD
Toremifene—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00271	CcSEcCtD
Toremifene—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00268	CcSEcCtD
Toremifene—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00268	CcSEcCtD
Toremifene—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00572	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00572	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00572	CbGpPWpGaD
Toremifene—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00267	CcSEcCtD
Toremifene—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000279	0.00571	CbGpPWpGaD
Toremifene—Pain—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00266	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00266	CcSEcCtD
Toremifene—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.00265	CcSEcCtD
Toremifene—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00264	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00264	CcSEcCtD
Toremifene—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.00263	CcSEcCtD
Toremifene—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.00263	CcSEcCtD
Toremifene—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000274	0.00561	CbGpPWpGaD
Toremifene—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.00261	CcSEcCtD
Toremifene—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00261	CcSEcCtD
Toremifene—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000272	0.0026	CcSEcCtD
Toremifene—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.0026	CcSEcCtD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000271	0.00555	CbGpPWpGaD
Toremifene—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00259	CcSEcCtD
Toremifene—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00259	CcSEcCtD
Toremifene—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00258	CcSEcCtD
Toremifene—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00256	CcSEcCtD
Toremifene—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00256	CcSEcCtD
Toremifene—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00548	CbGpPWpGaD
Toremifene—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000262	0.00535	CbGpPWpGaD
Toremifene—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000262	0.0025	CcSEcCtD
Toremifene—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.0025	CcSEcCtD
Toremifene—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.00248	CcSEcCtD
Toremifene—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.00248	CcSEcCtD
Toremifene—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00248	CcSEcCtD
Toremifene—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00527	CbGpPWpGaD
Toremifene—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.00246	CcSEcCtD
Toremifene—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000252	0.00516	CbGpPWpGaD
Toremifene—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00241	CcSEcCtD
Toremifene—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000244	0.00234	CcSEcCtD
Toremifene—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.00233	CcSEcCtD
Toremifene—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000243	0.00496	CbGpPWpGaD
Toremifene—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00228	CcSEcCtD
Toremifene—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00228	CcSEcCtD
Toremifene—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00225	CcSEcCtD
Toremifene—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00225	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000234	0.00478	CbGpPWpGaD
Toremifene—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00223	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000233	0.00476	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000231	0.00473	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000231	0.00473	CbGpPWpGaD
Toremifene—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00023	0.0022	CcSEcCtD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.00462	CbGpPWpGaD
Toremifene—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00216	CcSEcCtD
Toremifene—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00215	CcSEcCtD
Toremifene—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000223	0.00457	CbGpPWpGaD
Toremifene—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000223	0.00456	CbGpPWpGaD
Toremifene—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00212	CcSEcCtD
Toremifene—ESR1—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000221	0.00453	CbGpPWpGaD
Toremifene—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000219	0.0021	CcSEcCtD
Toremifene—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.0021	CcSEcCtD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—NOS3—chronic obstructive pulmonary disease	0.000219	0.00447	CbGpPWpGaD
Toremifene—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00206	CcSEcCtD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000212	0.00434	CbGpPWpGaD
Toremifene—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000212	0.00433	CbGpPWpGaD
Toremifene—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00202	CcSEcCtD
Toremifene—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00202	CcSEcCtD
Toremifene—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.002	CcSEcCtD
Toremifene—Rash—Formoterol—chronic obstructive pulmonary disease	0.000209	0.002	CcSEcCtD
Toremifene—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000209	0.002	CcSEcCtD
Toremifene—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.002	CcSEcCtD
Toremifene—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000209	0.002	CcSEcCtD
Toremifene—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00199	CcSEcCtD
Toremifene—Headache—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00199	CcSEcCtD
Toremifene—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00199	CcSEcCtD
Toremifene—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00198	CcSEcCtD
Toremifene—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00198	CcSEcCtD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000206	0.00421	CbGpPWpGaD
Toremifene—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	0.000205	0.116	CrCbGaD
Toremifene—Rash—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00196	CcSEcCtD
Toremifene—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00196	CcSEcCtD
Toremifene—Headache—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00195	CcSEcCtD
Toremifene—ESR1—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000203	0.00416	CbGpPWpGaD
Toremifene—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.115	CrCbGaD
Toremifene—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00193	CcSEcCtD
Toremifene—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00192	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00192	CcSEcCtD
Toremifene—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.0002	0.00409	CbGpPWpGaD
Toremifene—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00191	CcSEcCtD
Toremifene—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.00189	CcSEcCtD
Toremifene—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	0.000198	0.112	CrCbGaD
Toremifene—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00189	CcSEcCtD
Toremifene—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00189	CcSEcCtD
Toremifene—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00189	CcSEcCtD
Toremifene—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00189	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000197	0.00402	CbGpPWpGaD
Toremifene—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00188	CcSEcCtD
Toremifene—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.00398	CbGpPWpGaD
Toremifene—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00185	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000193	0.00395	CbGpPWpGaD
Toremifene—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000187	0.00383	CbGpPWpGaD
Toremifene—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000187	0.00383	CbGpPWpGaD
Toremifene—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00178	CcSEcCtD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00375	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	0.00018	0.00368	CbGpPWpGaD
Toremifene—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00172	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000178	0.00363	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—MMP9—chronic obstructive pulmonary disease	0.000175	0.00359	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00358	CbGpPWpGaD
Toremifene—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00166	CcSEcCtD
Toremifene—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00164	CcSEcCtD
Toremifene—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000167	0.0016	CcSEcCtD
Toremifene—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00157	CcSEcCtD
Toremifene—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000163	0.00334	CbGpPWpGaD
Toremifene—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00156	CcSEcCtD
Toremifene—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00155	CcSEcCtD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000162	0.00331	CbGpPWpGaD
Toremifene—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00154	CcSEcCtD
Toremifene—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00153	CcSEcCtD
Toremifene—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00147	CcSEcCtD
Toremifene—ESR1—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000153	0.00312	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000151	0.00309	CbGpPWpGaD
Toremifene—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00144	CcSEcCtD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000148	0.00302	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000147	0.00302	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000145	0.00296	CbGpPWpGaD
Toremifene—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00138	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000144	0.00294	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000138	0.00281	CbGpPWpGaD
Toremifene—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00281	CbGpPWpGaD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00129	CcSEcCtD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000135	0.00276	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.000135	0.00276	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000133	0.00272	CbGpPWpGaD
Toremifene—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00125	CcSEcCtD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.00013	0.00265	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00265	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00265	CbGpPWpGaD
Toremifene—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00265	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000129	0.00264	CbGpPWpGaD
Toremifene—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00123	CcSEcCtD
Toremifene—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000128	0.00261	CbGpPWpGaD
Toremifene—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00121	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000126	0.00259	CbGpPWpGaD
Toremifene—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00121	CcSEcCtD
Toremifene—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000126	0.00258	CbGpPWpGaD
Toremifene—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00119	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000123	0.00252	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00248	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000119	0.00243	CbGpPWpGaD
Toremifene—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00114	CcSEcCtD
Toremifene—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00113	CcSEcCtD
Toremifene—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000117	0.0024	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000116	0.00237	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000115	0.00235	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.000115	0.00234	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000114	0.00234	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000114	0.00234	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000114	0.00233	CbGpPWpGaD
Toremifene—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00109	CcSEcCtD
Toremifene—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00108	CcSEcCtD
Toremifene—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00108	CcSEcCtD
Toremifene—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00108	CcSEcCtD
Toremifene—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00108	CcSEcCtD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000112	0.0023	CbGpPWpGaD
Toremifene—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00107	CcSEcCtD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00228	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000111	0.00227	CbGpPWpGaD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00225	CbGpPWpGaD
Toremifene—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00102	CcSEcCtD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000106	0.00217	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000106	0.00217	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000106	0.00216	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00214	CbGpPWpGaD
Toremifene—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00211	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000102	0.00208	CbGpPWpGaD
Toremifene—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00204	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	9.83e-05	0.00201	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.74e-05	0.00199	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	9.65e-05	0.00197	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.6e-05	0.00196	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	9.52e-05	0.00195	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	9.46e-05	0.00193	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	9.42e-05	0.00193	CbGpPWpGaD
Toremifene—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000896	CcSEcCtD
Toremifene—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000884	CcSEcCtD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.02e-05	0.00184	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	8.85e-05	0.00181	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	8.74e-05	0.00179	CbGpPWpGaD
Toremifene—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000826	CcSEcCtD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	8.57e-05	0.00175	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	8.57e-05	0.00175	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.49e-05	0.00174	CbGpPWpGaD
Toremifene—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000794	CcSEcCtD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	8.28e-05	0.00169	CbGpPWpGaD
Toremifene—Rash—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.000788	CcSEcCtD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.23e-05	0.00168	CbGpPWpGaD
Toremifene—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.23e-05	0.000787	CcSEcCtD
Toremifene—Headache—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000783	CcSEcCtD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	8.16e-05	0.00167	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	8.16e-05	0.00167	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	8.14e-05	0.00167	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	8.13e-05	0.00166	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.12e-05	0.00166	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.08e-05	0.00165	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.01e-05	0.00164	CbGpPWpGaD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.98e-05	0.00163	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.85e-05	0.00161	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	7.76e-05	0.00159	CbGpPWpGaD
Toremifene—Nausea—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000742	CcSEcCtD
Toremifene—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.47e-05	0.00153	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.46e-05	0.00153	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.38e-05	0.00151	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.36e-05	0.00151	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	7.29e-05	0.00149	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	7.17e-05	0.00147	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	7.1e-05	0.00145	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.55e-05	0.00134	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	6.07e-05	0.00124	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.07e-05	0.00124	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.83e-05	0.00119	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.76e-05	0.00118	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.7e-05	0.00117	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.69e-05	0.00116	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	5.69e-05	0.00116	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.57e-05	0.00114	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.55e-05	0.00114	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.46e-05	0.00112	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.46e-05	0.00112	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.25e-05	0.00107	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.2e-05	0.00106	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.2e-05	0.00106	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.18e-05	0.00106	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.11e-05	0.00104	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5e-05	0.00102	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	4.97e-05	0.00102	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.93e-05	0.00101	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.79e-05	0.00098	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.76e-05	0.000973	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.76e-05	0.000973	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.73e-05	0.000966	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.69e-05	0.00096	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.6e-05	0.000941	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.55e-05	0.00093	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.53e-05	0.000926	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.51e-05	0.000922	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.45e-05	0.00091	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.23e-05	0.000864	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.22e-05	0.000864	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.19e-05	0.000858	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.14e-05	0.000847	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.06e-05	0.00083	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4e-05	0.000817	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.94e-05	0.000806	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.94e-05	0.000806	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	3.82e-05	0.000781	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.77e-05	0.000771	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.74e-05	0.000765	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.67e-05	0.000751	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	3.67e-05	0.00075	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.63e-05	0.000742	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.62e-05	0.000741	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.61e-05	0.000738	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.51e-05	0.000718	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.48e-05	0.000712	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.48e-05	0.000711	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.43e-05	0.000702	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.41e-05	0.000697	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.32e-05	0.000679	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.27e-05	0.000669	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.01e-05	0.000616	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.93e-05	0.000599	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.91e-05	0.000595	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.8e-05	0.000573	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.72e-05	0.000557	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.59e-05	0.000529	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.43e-05	0.000498	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.4e-05	0.000492	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.34e-05	0.000478	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.34e-05	0.000478	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.23e-05	0.000457	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.19e-05	0.000448	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.17e-05	0.000445	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.13e-05	0.000435	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.09e-05	0.000427	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2e-05	0.00041	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.98e-05	0.000405	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.98e-05	0.000404	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.86e-05	0.000379	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000378	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.84e-05	0.000376	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.82e-05	0.000373	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.00037	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.8e-05	0.000369	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000354	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.68e-05	0.000343	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000341	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.63e-05	0.000333	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.000327	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.6e-05	0.000327	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000323	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.48e-05	0.000303	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000295	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.43e-05	0.000292	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.4e-05	0.000287	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000284	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.00028	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000272	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.33e-05	0.000271	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.28e-05	0.000261	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000261	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.26e-05	0.000258	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000241	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.15e-05	0.000236	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000227	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000224	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.04e-05	0.000213	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000208	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.93e-06	0.000203	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.86e-06	0.000202	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.74e-06	0.000199	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.66e-06	0.000198	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.89e-06	0.000182	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.85e-06	0.000181	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.81e-06	0.00018	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.73e-06	0.000179	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	8.22e-06	0.000168	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.19e-06	0.000168	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.14e-06	0.000166	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.97e-06	0.000163	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.87e-06	0.000161	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.71e-06	0.000158	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.15e-06	0.000146	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.83e-06	0.00014	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.74e-06	0.000138	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.57e-06	0.000134	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.57e-06	0.000134	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.44e-06	0.000132	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.28e-06	0.000128	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.28e-06	0.000128	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.95e-06	0.000122	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.4e-06	0.000111	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.24e-06	0.000107	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.02e-06	0.000103	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.95e-06	0.000101	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.05e-06	8.28e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.87e-06	7.92e-05	CbGpPWpGaD
